Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study

Fig. 1

Age-associated risk of chronic inflammation and dyslipidemia for incident type 2 diabetes. P-INTm: Co-exposure subgroups and age-groups = 0.0193. G1: CumAIP < − 0.0699 and CumCRP < 1 mg/L; G2: CumAIP < -0.0699 and 1 ≤ CumCRP < 3 mg/L; G3: CumAIP < − 0.0699 and CumCRP ≥ 3 mg/L; G4: CumAIP ≥ − 0.0699 and CumCRP < 1 mg/L; G5: CumAIP ≥ − 0.0699 and 1 ≤ CumCRP < 3 mg/L; G6: CumAIP ≥ − 0.0699 and CumCRP ≥ 3 mg/L. All models were adjusted for age, sex, education, smoking status, drinking status, physical exercise, family history of diabetes, BMI, TC hypertension, eGFR antihypertensives (yes or no), and lipid-lowering agents (yes or no). Abbreviations as Table 1

Back to article page